The present invention is directed to a composition comprising from 0.1 to 10.0 wt % of a mixture of glycosaminoglycans comprising dermatan sulfate and chondroitin sulfate, wherein the amount of dermatan sulfate is at least 5% and not more than 95 % by weight, and the amount of chondroitin sulfate is at least 5% and not more than 95 % by weight, based on the total amount of glycosaminoglycans. Furthermore, the invention is also directed to the use of a glycosaminoglycans composition comprising dermatan sulfate and chondroitin sulfate, wherein the amount of dermatan sulfate is at least 5% and not more than 95 % by weight, and the amount of chondroitin sulfate is at least 5% and not more than 95 % by weight, based on the total amount of glycosaminoglycans, as an anti-age composition.La presente invencion se dirige a una composición que comprende de 0.1 a 10.0% en peso de una mezcla de glicosaminoglicanos que comprende dermatan sulfato y sulfato de condroitina, en donde la cantidad de dermatan sulfato es de al menos 5% y no mas de 95% en peso, y la cantidad del sulfato de condroitina es de al menos 5% y no mas de 95% en peso, con base en la cantidad total de glicosaminoglicanos. Ademas, la invencion tambien se refiere al uso de una composicion de glucosaminoglicanos que comprende dermatan sulfato y condroitinsulfato, en donde la cantidad de dermatan sulfato es de al menos 5% y no mas de 95% en peso, y la cantidad de sulfato de condroitina es de al menos 5% y no mas de 95% en peso, con base en la cantidad total de glicosaminoglicanos, tal como una composicion anti-edad.
